Physician profile
Mukesh Kumar
NPI 1659535086
$6,379.37
in general payments reported to CMS, 2019-2025
8 companies · $144 in 2025
The $144 reported for 2025 was more than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,762 · 2020: $232 · 2021: $109 · 2022: $12.60 · 2023: $121 · 2025: $144.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $264.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $5,415.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $565.62 | 2019-2021 | |
| Edwards Lifesciences Corporation | $143.81 | 2025 | Sapien 3 Ultra Resilia |
| Gilead Sciences, INC. | $105.52 | 2023 | Veklury |
| Novo Nordisk INC | $103.51 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $17.16 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.22 | 2023 | |
| Cti Biopharma Corp. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mukesh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.